The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of trifluridine/tipiracil (TAS-102) plus irinotecan in combination with bevacizumab as a second-line therapy for patients with metastatic colorectal cancer.
 
Yongkun Sun
No Relationships to Disclose
 
Jing Zhang
No Relationships to Disclose
 
Wenwei Yang
No Relationships to Disclose
 
Guifu Wu
No Relationships to Disclose
 
Xiaomin Zhong
No Relationships to Disclose
 
Wen Zhang
No Relationships to Disclose
 
Ping Liang
No Relationships to Disclose
 
Baoqi Li
No Relationships to Disclose
 
Chengxu Cui
No Relationships to Disclose